Clinical Trial

A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic Dermatitis

Name: A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic Dermatitis — clinical trial record (NCT07502222)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK139 in the treatment of patients with moderate-to-severe atopic dermatitis.

Trial Details

NCT Number	NCT07502222
Lead Sponsor	Akeso
Conditions	Moderate-to-Severe Atopic Dermatitis
Enrollment	168 participants
Start Date	2026-04-07
Primary Completion	2027-11 (estimated)
Study Completion	2028-01-10 (estimated)
Updated on ClinicalTrials.gov	2026-03-30